The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 05, 2024

Filed:

Oct. 29, 2020
Applicant:

Medtronic Minimed, Inc., Northridge, CA (US);

Inventors:

Garry M. Steil, Boston, MA (US);

Sami S. Kanderian, Jr., Germantown, MD (US);

Martin T. Cantwell, Canyon Country, CA (US);

Udo Hoss, Sherman Oaks, CA (US);

Assignee:

MEDTRONIC MINIMED, INC., Northridge, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61B 5/1486 (2006.01); A61B 5/1495 (2006.01); A61K 38/28 (2006.01); A61M 5/142 (2006.01); A61M 5/158 (2006.01); A61M 5/172 (2006.01); G16H 20/10 (2018.01); G16H 20/17 (2018.01); G16Z 99/00 (2019.01);
U.S. Cl.
CPC ...
A61B 5/14532 (2013.01); A61B 5/14865 (2013.01); A61B 5/4839 (2013.01); A61B 5/6849 (2013.01); A61B 5/7275 (2013.01); A61K 38/28 (2013.01); A61M 5/14244 (2013.01); A61M 5/1723 (2013.01); C12Y 301/01003 (2013.01); G16H 20/17 (2018.01); G16Z 99/00 (2019.02); A61B 5/1495 (2013.01); A61M 2005/14208 (2013.01); A61M 5/158 (2013.01); A61M 2005/1581 (2013.01); A61M 5/1582 (2013.01); A61M 2205/3523 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3569 (2013.01); G16H 20/10 (2018.01);
Abstract

Disclosed herein are techniques related to model predictive control. The techniques may involve generating a desired glucose trajectory that approaches a desired steady state setpoint from a current glucose value over a prediction horizon. The techniques may involve generating a plurality of insulin delivery patterns. Each insulin delivery pattern may correspond to an amount of insulin to be delivered over a control horizon. The techniques may involve generating a plurality of predicted glucose trajectories over the control horizon. Each predicted glucose may be generated based on the current glucose value and a respective insulin delivery pattern. The techniques may involve comparing the desired glucose trajectory against each predicted glucose trajectory and selecting a predicted glucose trajectory that is more similar to the desired glucose trajectory than any other predicted glucose trajectory. The techniques may involve determining an insulin delivery pattern used to generate the selected predicted glucose trajectory.


Find Patent Forward Citations

Loading…